Abstract
Background
Researchers are increasingly motivated to move toward patient-centric drug development. TransCelerate has identified improved “information exchange” as an important component of creating a more satisfying clinical trial experience for patients and their health care professionals (HCPs).
Methods
Patients, sponsors, sites, and HCPs were engaged through surveys, interviews, and/or advisory boards to capture the current status of information exchange and identify possible future practices between the major stakeholders within the clinical research ecosystem.
Results
Data suggest that patients have numerous desires and preferences for information exchange during their clinical trial journey that are not commonly met. Various opportunities exist to improve the clinical trial participants’ experiences by improving information exchange practices across various stages of the participant’s journey.
Conclusions
A shift in industry focus toward more comprehensive information exchange with trial participants has the potential to positively impact many patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Perfetto EM, Oehrlein EM, Anyanwu C, et al. Stakeholder Perspectives on Patient-Focused Drug Development: Insights From FDA, Patients, Industry, and Payers. Baltimore, MD: University of Maryland School of Pharmacy, 2015.
Smith SK, Selig W, Harker M, et al. Patient engagement practices in clinical research among patient groups, industry, and academia in the United States: a survey. PLoS One. 2015;10:e0140232.
Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines: a call for action. Therapeutic Innovation & Regulatory Science. 2015;49:929–939.
Perfetto EM, Burke L, Oehrlein EM, et al. Patient-focused drug development: a new direction for collaboration. Med Care. 2015;53:9–17.
Boutin M, Dewulf L, Hoos A, et al. Culture and process change as a priority for patient engagement in medicines development. Therapeutic Innovation & Regulatory Science. 2016;51:29–38.
Estimated number of people needed to fulfill demand among all enrolling studies on clinicaltrials.gov. http://enrollment-demand.lillycoi.com. Accessed March 17, 2017.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Dietrich, J., Alivojvodic, J., Seliverstov, I. et al. Improving Information Exchange with Clinical Trial Participants: A Proposal for Industry. Ther Innov Regul Sci 51, 542–550 (2017). https://doi.org/10.1177/2168479017725109
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479017725109